Home World News FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell Precursor... World News FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia By Ogkologos - December 3, 2024 980 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the FELIX study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Διαφημιστείτε January 18, 2019 Grabbing the Perfect Gift December 16, 2023 EMA Recommends Extension of Therapeutic Indications for Cabozantinib April 29, 2022 How Finding the Right Primary Care Physician During Cancer Has Helped... March 24, 2021 Load more HOT NEWS Does Eating Processed Meat Increase Your Risk for Cancer? Dual Antigen Targeting with Talquetamab plus Teclistamab in Patients with Relapsed... FDA Approves Olaparib with Abiraterone and Prednisone (or Prednisolone) for BRCA-mutated... Adjuvant Selpercatinib Prolongs EFS Among Patients with Stage II or IIIA...
